OBI Pharma Common Stock

OBI Pharma (4174.TWO) currently reports a common stock of $1.3B as of June 2026. That compares with $2.6B in the prior-year period — down 50.0% year over year. Use the charts on this page to explore OBI Pharma's common stock history and peer comparisons.

OBI Pharma's common stock decreased from $2.6B to $1.3B — a 50.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OBI Pharma reported $1.3B in common stock as of June 2026. That compares with $2.6B in the prior-year period — down 50.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OBI Pharma, and consider following 4174.TWO for alerts when major investors trade the stock.

OBI Pharma is classified in the Healthcare sector. On common stock, it currently shows $1.3B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4174.TWO with unrelated industries.